Open-label, multicenter safety study of vemurafenib in patients with BRAF(V600) mutation-positive metastatic melanoma

James M. G. Larkin, Michele Del Vecchio, Paolo Antonio Ascierto, Jacob Schachter, Claus Garbe, Bart Neyns, Mario Mandala, Paul Lorigan, Wilson H. Miller, Alexander David Guminski, Carola Berking, Piotr Rutkowski, Paola Queirolo, Axel Hauschild, Ana Maria Arance, Michael Paul Brown, Lada Mitchell, Maria Luisa Veronese, Christian U. Blank

    Research output: Contribution to journalArticlepeer-review

    Original languageUndefined
    Article number9046
    JournalJournal of Clinical Oncology
    Volume15
    Issue numberS
    Publication statusPublished - 2013

    Cite this